Melanoma surgery study for patients 75 and older
Part of Cancer, Skin clinical trials.
This study compares different ways to manage newly diagnosed melanoma in older adults. It looks at how well surgery plus lymph node biopsy works and how it affects quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years old or older.
- You have a new melanoma on your skin that has not been treated yet.
- You are able to have surgery to remove the melanoma and a nearby lymph node for testing.
- You are in generally good health, able to do daily activities with little or no help.
- You speak English, Spanish, or (in Canada) French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors decide the safest surgical approach for melanoma and similar skin tumors in children and young adults by using pathology reports and genetic information. The goal is to avoid unnecessary surgery while ensuring the best outcomes.
This study tests a new way to monitor people after surgery for early-stage melanoma. If you qualify, it may help your doctors watch for changes sooner or more accurately during follow-up.
This trial studies whether removing a slightly wider strip of skin around a melanoma improves outcomes compared with a narrower strip. It also uses a lymph node staging procedure to check spread and helps doctors fine-tune surgery for stage II melanoma.
This trial tests whether removing a clinically involved lymph node basin (via a specific lymph node excision surgery) after certain melanoma findings is helpful. It mainly aims to see effects on outcomes and on arm/leg swelling (lymphedema) after surgery.
This trial compares two surgeries for invasive melanoma: a narrow removal versus a wider one. It aims to see if a smaller surgery works as well, which could mean less scarring and recovery time.
This study tests whether patients with moderate-thickness skin melanoma need additional surgery after their initial tumor removal, or if careful monitoring alone is enough. The goal is to avoid unnecessary surgery while keeping patients safe.
Hear when a new Cutaneous Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.